Global HEK293 Cell Line Supply, Demand and Key Producers, 2023-2029

Global HEK293 Cell Line Supply, Demand and Key Producers, 2023-2029

The global HEK293 Cell Line market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Increasing demand for HEK293 cell lines, development of biomedical research technologies, clinical applications of cell therapy and gene therapy, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth of the HEK293 cell line market revenue.

The HEK293 cell line is a permanent line established from primary embryonic human kidney, which was transformed with sheared human adenovirus type 5 DNA. The adenoviral genes expressed in this cell line allow the cells to produce very high levels of recombinant proteins.

Due to the multiple copies of adenovirus E1A and E1B genes, HEK293 cells have a high transfection efficiency. This makes them useful in biotechnology, especially protein expression, gene therapy and vaccine production.



The pharmaceutical industry uses HEK293 cells for high-throughput screening assays because they can be transfected with plasmids encoding drug targets and grown in large numbers.



In industrial biotechnology, HEK293 cells are used to produce recombinant proteins and enzymes and to develop biosensors. Toxicology researchers, on the other hand, use HEK293 cells to study the effects of chemicals and environmental toxins on cellular processes and gene expression.



HEK293 cells are also used to produce recombinant viruses, such as adenoviruses and lentiviruses, for gene therapy, viral replication, and host-virus interactions.



Overall, the HEK293 cell line is versatile and can be used in biomedical research with applications in biotechnology, pharmaceuticals, and toxicology.

This report studies the global HEK293 Cell Line production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for HEK293 Cell Line, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HEK293 Cell Line that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global HEK293 Cell Line total production and demand, 2018-2029, (K Units)

Global HEK293 Cell Line total production value, 2018-2029, (USD Million)

Global HEK293 Cell Line production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global HEK293 Cell Line consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: HEK293 Cell Line domestic production, consumption, key domestic manufacturers and share

Global HEK293 Cell Line production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global HEK293 Cell Line production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global HEK293 Cell Line production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global HEK293 Cell Line market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Altogen Biosystems, ATCC, Synthego, CLS, Thermo Fisher Scientific, Beckman Coulter, Sigma Aldrich, Sartorius and Promega, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HEK293 Cell Line market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global HEK293 Cell Line Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global HEK293 Cell Line Market, Segmentation by Type
293T
293H
293E
293F
293S
293SGGD
Others

Global HEK293 Cell Line Market, Segmentation by Application
Protein Production
Receptor Signal Transduction
Drug Testing
Cancer Research
Others

Companies Profiled:
Altogen Biosystems
ATCC
Synthego
CLS
Thermo Fisher Scientific
Beckman Coulter
Sigma Aldrich
Sartorius
Promega
Kerafast
Biocompare
InvivoGen
Innoprot
Takara
Henan Punuoyi Biological
Porton Pharma Solutions
Ubigene Biosciences

Key Questions Answered

1. How big is the global HEK293 Cell Line market?

2. What is the demand of the global HEK293 Cell Line market?

3. What is the year over year growth of the global HEK293 Cell Line market?

4. What is the production and production value of the global HEK293 Cell Line market?

5. Who are the key producers in the global HEK293 Cell Line market?

6. What are the growth factors driving the market demand?